Skip to Main Content

INFORMATION FOR

Yale Medicine

About Yale Medicine

Yale Medicine is a multi-specialty academic group practice that strives to provide the highest quality health care. Through its clinical activity, YM also supports the medical education, training, and clinical research missions of the Yale School of Medicine (YSM).

Yale Medicine Leadership

  • Deputy Dean & CEO, Yale Medicine

    Margaret McGovern, MD, PhD, is deputy dean for clinical affairs and chief executive officer of Yale Medicine, the clinical practice of Yale School of Medicine. In that role, she leads a rapidly growing multispecialty medical practice with more than 1,600 full-time and part-time physicians.Before joining Yale, Dr. McGovern was Knapp Professor of Pediatrics and dean for clinical affairs at Renaissance School of Medicine at Stony Brook University, and vice president of Stony Brook Medicine Health System clinical programs and strategy. Prior to assuming those roles in 2018, she was chair of Pediatrics and physician-in-chief at Stony Brook Children’s Hospital. She led the development and planning of Stony Brook Children’s Hospital and significantly expanded its pediatric clinical research and education programs. Dr. McGovern received her PhD in genetics from the Mount Sinai Graduate School of Biomedical Sciences and her MD from Mount Sinai School of Medicine (now called Icahn School of Medicine at Mount Sinai). She completed her residency in pediatrics and fellowships in clinical and molecular genetics at Mount Sinai Hospital before joining the faculty. At Icahn School of Medicine, she was vice chair of the Department of Genetics and Molecular Medicine and professor of human genetics, and of oncological sciences and obstetrics and gynecology. She also was program director for the NIH-funded General Clinical Research Center and carried out CDC- and NIH-funded research focused primarily on the integration of molecular genetic diagnostic testing into clinical practice and inborn errors of metabolism. Dr. McGovern is considered a world authority on sphingolipidoses, a heterogeneous group of inherited disorders of lipid metabolism primarily affecting the central nervous system and chiefly occurring in the pediatric population.

Yale Medicine Teams

Organizations on this page

  • Skip List Items
  • Yale Medicine Leadership

    • Dean, Yale School of Medicine

      Jean and David W. Wallace Dean of the Yale School of Medicine and C.N.H. Long Professor of Internal Medicine

      Dr. Brown graduated from Yale College, where she majored in molecular biophysics and biochemistry. She earned her medical degree from Harvard University. She completed internship and residency programs in medicine at Vanderbilt University, where she also did a fellowship in clinical pharmacology. Dr. Brown joined the faculty of Vanderbilt in 1992 and held a number of leadership positions, serving as chief of the Division of Clinical Pharmacology, associate dean for clinical and translational scientist development, and Robert H. Williams professor before becoming the Hugh J. Morgan Chair of Medicine and physician-in-chief of Vanderbilt University Hospital in 2010. In 2020, she became Jean and David W. Wallace Dean of Medicine and C.N.H. Long Professor of Internal Medicine at Yale School of Medicine. Dr. Brown has long been committed to medical education and mentorship. At Vanderbilt, she established the Elliot Newman Society to support the development of physician-scientists and co-founded the Vanderbilt Master of Science in Clinical Investigation program. Her research has defined the molecular mechanisms through which commonly prescribed blood pressure and diabetes drugs affect the risk of cardiovascular and kidney disease. In her clinical practice, she has treated patients with resistant and secondary forms of hypertension. Dr. Brown has served as a member of the NIH National Advisory Research Resources Council and the National Heart, Lung, and Blood Advisory Council. She was president of the Association of Professors of Medicine. In 2019, she was elected a Master of the American College of Physicians.Her numerous awards include election to the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine.   She is a member of the American Association of Arts and Sciences.
    • Chief Executive Officer

      Deputy Dean & CEO, Yale Medicine

      Margaret McGovern, MD, PhD, is deputy dean for clinical affairs and chief executive officer of Yale Medicine, the clinical practice of Yale School of Medicine. In that role, she leads a rapidly growing multispecialty medical practice with more than 1,600 full-time and part-time physicians.Before joining Yale, Dr. McGovern was Knapp Professor of Pediatrics and dean for clinical affairs at Renaissance School of Medicine at Stony Brook University, and vice president of Stony Brook Medicine Health System clinical programs and strategy. Prior to assuming those roles in 2018, she was chair of Pediatrics and physician-in-chief at Stony Brook Children’s Hospital. She led the development and planning of Stony Brook Children’s Hospital and significantly expanded its pediatric clinical research and education programs. Dr. McGovern received her PhD in genetics from the Mount Sinai Graduate School of Biomedical Sciences and her MD from Mount Sinai School of Medicine (now called Icahn School of Medicine at Mount Sinai). She completed her residency in pediatrics and fellowships in clinical and molecular genetics at Mount Sinai Hospital before joining the faculty. At Icahn School of Medicine, she was vice chair of the Department of Genetics and Molecular Medicine and professor of human genetics, and of oncological sciences and obstetrics and gynecology. She also was program director for the NIH-funded General Clinical Research Center and carried out CDC- and NIH-funded research focused primarily on the integration of molecular genetic diagnostic testing into clinical practice and inborn errors of metabolism. Dr. McGovern is considered a world authority on sphingolipidoses, a heterogeneous group of inherited disorders of lipid metabolism primarily affecting the central nervous system and chiefly occurring in the pediatric population.
    • Associate Dean for Clinical Affairs and Chief Medical Officer

      Associate Dean for Clinical Affairs; Chief Medical Officer for YM; & Associate Professor of Neurology; Chief Ambulatory Medical Officer, Yale Medicine and Yale New Haven Health; Vice-Chair, Operations, Neurology; Director, MDA-ALS/Motor Neuron Disease Clinic, Neurology

      Dr. Babar Khokhar is the associate dean for clinical affairs and chief medical officer of Yale Medicine (YM). In that role, Dr. Khokhar oversees such areas as clinical innovation, YM regional medical directors, credentialing, patient relations, and risk management. He also oversees Yale Clinical Optimization Services, a program he founded that is dedicated to the transformation of ambulatory care focusing on value, efficiency and the patient and physician/provider experience. Within the Department of Neurology, Dr. Khokhar serves as vice chair for operations and director of the MDA-ALS Clinic. As vice chair, he oversees outpatient neurology practices within the department and has helped expand ambulatory access to neurological services across the state. Dr. Khokhar graduated with honors from Johns Hopkins University, majoring in neuroscience and economics. He then earned his MD and MBA in healthcare management in a combined four-year program at Tufts University. After completing his neurology residency and neuromuscular medicine fellowship at Yale New Haven Hospital, he joined the Yale Department of Neurology as a faculty member. His clinical interests include motor neuron diseases such Amyotrophic Lateral Sclerosis (ALS) as well as other neuromuscular disorders. His other interests included medical education and health care administration, focusing on optimizing the delivery of ambulatory care and improving both the patient and provider experience in such delivery models.
    • Chair of the YM Board

      William H. Carmalt Professor of Surgery; Chair, Surgery

      Nita Ahuja, MD, MBA, is the chair of the Department of Surgery at Yale School of Medicine and chief of surgery at Yale New Haven Hospital, effective February 1, 2018. Watch a video with Dr. Nita Ahuja>>Dr. Ahuja obtained her medical education at the Duke University School of Medicine and her training in general surgery at Johns Hopkins. She completed a fellowship in surgical oncology at Johns Hopkins focused on hepatobiliary malignancies and joined the faculty in 2003. Dr Ahuja's surgical specialization is in management of sarcomas and complex gastrointestinal cancers, including gastric, rectal, and pancreatic cancers. She has developed an international reputation for management of peritoneal cancer metastases with cytoreduction and heated intraperitoneal chemotherapy, which attracts patients from around the world. She is a strong advocate for working with various disciplines to deliver caring and cutting edge treatment to her patients and is honored as a top doctor by multiple organizations. Prior to coming to Yale as chair of surgery, she was the director of sarcoma program and gastric cancer program.Dr. Ahuja is also a passionate advocate of clinician scientist and has run a laboratory focused on developing new knowledge to improve cancer outcomes. Her NIH funded laboratory has been focused on identifying new biomarkers for pancreas and colon cancers using liquid biopsies and stool DNA. She has also led over twenty national and international clinical trials on testing new therapies in gastrointestinal and breast cancers based on concepts identified in her laboratory.She is a national and international surgical leader and surgeon scientist who serves on multiple editorial boards and in national leadership positions including as an elected member of the National Academy of Medicine, member of the American Surgical Association, New England Surgical Society, Southern Surgical Association and on the Association of American Medical Colleges Council of Faculty and Academic Societies Administrative Board. She has published over 300 papers and book chapters contributing to both the surgical and basic science fields. Her many awards and honors include the William J. Reinhoff, Jr. Scholar Award, the American Surgical Association Fellowship, the Society of Surgical Oncology Clinical Investigator Award, and the Abell Foundation Award: Johns Hopkins Alliance for Science and Technology Development.
    • Chief Information Officer

      Lecturer; Sr. Vice President, Administration

      Mrs. Stump is Senior Vice President and Chief Information Officer at Yale New Haven Health System and Yale School of Medicine.  Mrs. Stump graduated from the Univ. of Connecticut School of Pharmacy and The Ohio State University College of Pharmacy with a Master's degree in Pharmacy Administration.  Mrs. Stump is an active lecturer, commentator, and speaker on healthcare IT and digital health.  She is Adjunct Professor and a member of the Board of Visitors of the College of Health Professionals at Sacred Heart University.
  • Yale Medicine Board Members

    • Chair

      William H. Carmalt Professor of Surgery; Chair, Surgery

      Nita Ahuja, MD, MBA, is the chair of the Department of Surgery at Yale School of Medicine and chief of surgery at Yale New Haven Hospital, effective February 1, 2018. Watch a video with Dr. Nita Ahuja>>Dr. Ahuja obtained her medical education at the Duke University School of Medicine and her training in general surgery at Johns Hopkins. She completed a fellowship in surgical oncology at Johns Hopkins focused on hepatobiliary malignancies and joined the faculty in 2003. Dr Ahuja's surgical specialization is in management of sarcomas and complex gastrointestinal cancers, including gastric, rectal, and pancreatic cancers. She has developed an international reputation for management of peritoneal cancer metastases with cytoreduction and heated intraperitoneal chemotherapy, which attracts patients from around the world. She is a strong advocate for working with various disciplines to deliver caring and cutting edge treatment to her patients and is honored as a top doctor by multiple organizations. Prior to coming to Yale as chair of surgery, she was the director of sarcoma program and gastric cancer program.Dr. Ahuja is also a passionate advocate of clinician scientist and has run a laboratory focused on developing new knowledge to improve cancer outcomes. Her NIH funded laboratory has been focused on identifying new biomarkers for pancreas and colon cancers using liquid biopsies and stool DNA. She has also led over twenty national and international clinical trials on testing new therapies in gastrointestinal and breast cancers based on concepts identified in her laboratory.She is a national and international surgical leader and surgeon scientist who serves on multiple editorial boards and in national leadership positions including as an elected member of the National Academy of Medicine, member of the American Surgical Association, New England Surgical Society, Southern Surgical Association and on the Association of American Medical Colleges Council of Faculty and Academic Societies Administrative Board. She has published over 300 papers and book chapters contributing to both the surgical and basic science fields. Her many awards and honors include the William J. Reinhoff, Jr. Scholar Award, the American Surgical Association Fellowship, the Society of Surgical Oncology Clinical Investigator Award, and the Abell Foundation Award: Johns Hopkins Alliance for Science and Technology Development.
    • Waldemar Von Zedtwitz Professor of Pediatrics; Chair, Pediatrics; Chief Medical Officer, Yale-New Haven Children's Hospital

      Clifford W. Bogue, MD, a pediatric critical care specialist, is the Waldemar Von Zedtwitz Professor and Chairman of Pediatrics at Yale School of Medicine, where he has been on the faculty since 1993.  In 2014, he was also named the inaugural Chief Medical Officer of Yale-New Haven Children’s Hospital, where he provides strategic and operational leadership for the Children’s Hospital’s clinical delivery systems. Dr. Bogue was named Chairman of the Department of Pediatrics in August, 2017.  Dr. Bogue received both his undergraduate and medical degrees from the University of Virginia (UVA).  He was a resident and chief resident in pediatrics at Vanderbilt University before completing a fellowship in pediatric critical care medicine at Yale.During his career at Yale, Dr. Bogue has held a number of medical school and hospital leadership positions, including Director of Pediatric Critical Care Transport, Medical Director of the Pediatric Intensive Care Unit, Director of the Pediatric Critical Care Fellowship, Chief of Pediatric Critical Care Medicine and Associate Chairman for Strategic Planning. From 2010 – 2012, he served as Interim Chairman of Pediatrics and Physician-in-Chief of Yale New Haven Children’s Hospital and from 2012 – 2015 served as Vice Chairman of the Department of Pediatrics. He served as Interim Chairman of Pediatrics from 2015 – 2017.Dr. Bogue has been actively involved in training students, residents and fellows and is committed to the development of pediatric physician-scientists.  He was director of Bedside to Bench: Seminars in Pediatrics, a course for first-year medical students for over ten years, served on the MD/PhD Faculty Committee, was PI for an NIH T32 training program in cardiopulmonary development for 10 years. He most recently served as training director for the Yale Child Health Research Center, a K12 program funded by the NICHD that had 25 years of consecutive funding. He has served on several NIH peer review panels and is currently a member of the Child Health Research Scientific Review Committee of the Charles H. Hood Foundation.  He previously served as Co-Chair of the American Heart Association Genetics/Epigenetics peer review committee. In 2014, Dr. Bogue was the Chair of the Planning Committee for Pediatric Clinical Trials Network Stakeholders’ Forum, a forum convened by the American Academy of Pediatrics to initiate the process of developing a global pediatric clinical trials network. Dr. Bogue served on two NIH Advisory Committees of the NIH focused on the inclusion of children in research and in the Precision Medicine Program Initiative All of Us.Dr. Bogue’s academic career at Yale also included establishing and directing an NIH-funded research program in the developmental biology of the lung, liver and cardiovascular system for over 20 years.  During that time, his laboratory made important contributions to the genetic pathways involved in embryonic organ development, including the identification of genetic pathways critical to formation of the liver and biliary system as well as the cardiovascular system.Dr. Bogue has served on a number of national and international boards in academic pediatrics including the Council of the Society for Pediatric Research, the Federation of Pediatric Organizations’ Child Health Research and Training Workgroup, and the Program Committee of the Pediatric Academic Societies’ Meeting where he served as Chair from 2015 - 2017.  He is currently a Trustee and President of the International Pediatric Research Foundation (which is responsible for publishing the journal Pediatric Research), Secretary-Treasurer of the American Pediatric Society, Chair of the AAP Committee on Pediatric Research, and Section Editor for Current Opinion in Pediatrics. He has been named annually to Best Doctors in America since 2004 and was awarded both the Mae Gailani Young Investigator and Norman J Siegel Faculty Awards at the Yale School of Medicine.
    • Associate Dean for Physician-Scientist Development and Professor of Dermatology, Pathology and Genetics; Chair, Dermatology

      Keith Choate M.D., Ph.D., is a physician-scientist who employs tools of human genetics to understand fundamental mechanisms of disease. His laboratory studies rare inherited and mosaic skin disorders to identify novel genes responsible for epidermal differentiation and development.  His laboratory has identified the genetic basis of over 12 disorders and has developed new therapeutic approaches informed by genetic findings.  His laboratory is funded by the National Institute of Arthritis and of Musculoskeletal and Skin Diseases, a division of the National Institutes of Health.Dr. Choate mentors undergraduate, graduate, and medical students in his laboratory, teaches at Yale Medical School, and trains resident physicians and fellows.
    • Robert R. Young Professor of Ophthalmology and Visual Science; Chair, Ophthalmology; Chief of Ophthalmology, Yale New Haven Hospital

      Lucian V. Del Priore, MD, PhD specializes in the surgical and medical treatment of retinal disease, including age-related macular degeneration, retinal detachment, diabetic retinopathy, macular holes, epiretinal membranes, and ocular trauma. He received his BS in Physics from the Cooper Union for the Advancement of Science and Art, an MD with Distinction in Research from the University of Rochester School of Medicine and Dentistry, and an MS and PhD in Physics from Cornell University.  He completed a residency in Ophthalmology and fellowships in Vitreoretinal Surgery and Glaucoma at the Wilmer Eye Institute of the Johns Hopkins Hospital.  He has served on the faculty of Washington University School of Medicine and Columbia University, where he rose to the ranks of Professor and Robert L. Burch III Scholar in the Department of Ophthalmology and was a member of the Stem Cell Consortium.  Prior to coming to Yale, he was the Pierre G. Jenkins Professor and Chair of the Department of Ophthalmology and Visual Science, Professor of Regenerative Medicine and Director of the Albert Florens Storm Eye Institute at MUSC in Charleston, SC.          Dr. Del Priore is a member of the American Academy of Ophthalmology, the Macula Society, the Retina Society, the American Society of Retinal Specialists, the Association for Research in Vision and Ophthalmology, and the International Society for Eye Research.  Dr. Del Priore has published extensively in the peer-reviewed literature and has given numerous invited lectures throughout the world on the treatment of retinal diseases.  He maintains an active research laboratory in the biology of retina in health and disease.  He was recently elected to the New York Ophthalmological Society, and is a Life Fellow and Member of the American Academy of Ophthalmology, having previously received a Senior Achievement Award in recognition of commitment to advancing the profession. He has also received a Senior Honor Award from the American Society of Retina Specialists, and is a Fellow of the Association for Research in Vision and Ophthalmology. He has received an MA (honorary) from Yale University, and a Distinguished Alumnus Award from the Wilmer Ophthalmological Institute at Johns Hopkins in recognition of outstanding contributions to ophthalmology as a Wilmer Graduate. He has received the Lew R. Wasserman Award from Research to Prevent Blindness and a Teacher of the Year Award. He is listed consistently within the Castle Connolly Guide to America’s Top Doctors, as well as Connecticut Magazine Best Doctors.
    • Vice Provost for Faculty Development and Diversity; Chair, Department of Internal Medicine; and Paul B. Beeson Professor of Medicine; Affiliated Faculty, Yale Institute for Global Health

      Gary Désir M.D. is the Beeson Professor of Medicine at the Yale University School of Medicine (YSM) and serves as chair of the Department of Internal Medicine at YSM, and chair of the board of Yale Medicine.  He is a physician-scientist whose work has been funded by the National Science Foundation, National Institute of Health, Department of Veterans Affairs, American Heart Association, and the Robert Wood Johnson foundation. His major contributions to science include the discovery a specific voltage-gated potassium channel that regulates body weight and insulin sensitivity, and the identification of a new growth factor, which he named renalase. He elucidated the pathway through which renalase affects cellular signaling and discovered that the protein can function abnormally and facilitate the development of certain cancers. Hi laboratory is currently focused on developing drugs that can treat cancer by blocking the action of renalase in cancer cells. Dr. Désir is a named inventor on several patents related to the discovery and therapeutic use of renalase, and the development of drugs that modulate renalase signaling in cancer. He is the scientific founder of 2 biotechnology companies focused on developing renalase-based therapies.Dr. Désir, the first person of African descent to be appointed as chair of a department at YSM, has a strong interest in issues of diversity and social justice. He is the co-founder of the minority organization for retention and expansion (MORE), a faculty group at YSM focused on increasing faculty diversity through mentoring programs and developing resilient social networks. In collaboration with Gordon Geballe, Associate Dean for Alumni and External Affairs at school of Forestry and Environmental Studies, he has worked with L’Hospital Albert Schweitzer in the Artibonite valley in Haiti on integrated projects designed to improve the standard of living in the valley.  He was born in Port-Au-Prince, Haiti. After high school, he immigrated to the US to attend New York University, from which he graduated magna cum laude, with a bachelor’s degree in biology. He was elected to the Phi Beta Kappa Society, and also received New York University’s Founders Day award. Following graduation from Yale University School of Medicine (Cum Laude, Alpha Omega Alpha honor society), he trained in internal medicine and nephrology at Yale New Haven Hospital.  Dr. Désir is married to Dr. Deborah Dyett Désir who practices rheumatology at Yale. They have four children, Carl, Matthew, Christopher and Alexandra, a granddaughter Elodie and a grandson Amari.
    • Fergus F. Wallace Professor of Genetics; Chair, Genetics

      Antonio studied Chemistry and Molecular Biology at the University of Cadiz and the University Autonoma of Madrid. During undergraduate, he worked with Gines Morata at the CBM in Madrid. Antonio did his PhD with Stephen Cohen at the EMBL (Heidelberg) (1998-2002) and a post-doc with Alex Schier at the Skirball Institute (NYU) and Harvard (2003-2006). Antonio established his laboratory at Yale in 2007 where he investigates the regulatory codes that shape gene expression during embryonic development. He was Director of Graduate Studies (2012-2016) and is currently Chair of the Genetics Department (2017- ).
    • Robert E. Hunter Professor of Therapeutic Radiology and Professor of Genetics; Chair, Therapeutic Radiology

      Radiation oncologist Peter M. Glazer, MD, PhD, is the chair of the Department of Therapeutic Radiology. He has dedicated his career to helping cancer patients receive the highest quality of care available in a supportive environment.“When patients are undergoing radiotherapy for cancer, it can be a sensitive and challenging time for them and their families,” he says. “Our team does everything possible to keep our patients safe and comfortable throughout treatment.” Dr. Glazer makes it his priority to provide patients seeking care at Smilow Cancer Hospital and its Care Centers with the most advanced technologies and evidence-based treatments. “We take great pride in giving our physicians the best tools to treat cancer,” he says.As a professor of both therapeutic radiology and genetics at Yale School of Medicine, Dr. Glazer researches new therapeutic strategies for treating cancer and the role of altered DNA repair in tumor progression. His research was recently recognized by the National Cancer Institute of the NIH with a prestigious Outstanding Investigator Award of $7 million that will support his efforts to develop novel DNA repair inhibitors for cancer therapy.
    • Professor of Radiology and Biomedical Imaging; Chair, Radiology and Biomedical Imaging; Radiologist-in-Chief, Yale New Haven Health

      Rob Goodman, MB BChir, MBA is the Chair of the Department of Radiology & Biomedical Imaging at Yale School of Medicine, Chief of Radiology at Yale New Haven Hospital and Radiologist-in-Chief at Yale New Haven Health System.Dr. Goodman joined Yale in 2004 from the John Radcliffe Hospital in Oxford, UK, where he was lead clinician for its radiology department. He obtained his medical degree from Cambridge University in 1988 and an MBA in Healthcare from Yale in 2017. Upon completing his residency at the Central Oxford Hospitals in the UK, he did a fellowship in pediatric radiology at The Hospital for Sick Children in Toronto. After his relocation from Europe to the United States, he was struck by the marked differences in radiation awareness between the two countries, which is particularly relevant in pediatric radiology due to children’s susceptibility to the effects of radiation. He subsequently played a major role in the movement to reduce radiation exposure from CT scans in children, as well as adults. As a way to reduce radiation exposure, his clinical interests also included improved utilization of ultrasound in pediatric imaging. He has published and lectured on these topics nationally and is the Pediatric Community of Practice President for the American Institute for Ultrasound in Medicine, and sits on its Board of Governors. He has been involved in developing national consensus guidelines for such topics as neonatal echoencephalography, pediatric spinal ultrasound, hip ultrasound, and imaging in pregnant patients. During his tenure at Yale, Dr. Goodman has overseen the expansion of pediatric radiology services, spearheaded the installation of a dedicated pediatric MRI scanner at Yale New Haven Children’s Hospital, implemented a critical test result reporting system, and identified mechanisms to improve the radiology peer review process. He recently helped execute an imaging industry relationship with Siemens Healthcare for Yale New Haven Health System. As Chair, Dr. Goodman is building upon the department’s clinical strengths and world-class research taking place in such areas as novel MR pulse sequences, functional MRI, MR spectroscopy, novel PET tracers, and advanced image processing. By including industry partners, he is eager to expand its translational research program to help convert basic science discoveries into clinical applications that improve patient care.
    • Nixdorff-German Professor of Neurosurgery and Professor of Genetics and of Neuroscience; Chair, Neurosurgery; Chief, Neurosurgery, Yale New Haven Health System; Chair, Perioperative Executive Leadership Committee; Member, National Academy of Medicine; Co-Director, Yale Program on Neurogenetics

      Dr. Murat Günel, the Nixdorff-German Professor of Neurosurgery and Professor of Neurobiology and Genetics, was appointed Chair of the Department of Neurosurgery at Yale School of Medicine and Chief of Neurosurgery at Yale-New Haven Hospital in 2014. He is the director of the Yale Program in Brain Tumor Research and co-director of the Yale Program on Neurogenetics. Dr. Günel obtained his medical degree at Istanbul University and completed both his internship and residency at Yale-New Haven Hospital. His clinical expertise is in treating complex brain aneurysms and vascular malformations, as well as brain tumors. Dr. Günel’s research interest focuses on gene discovery in diseases of the human brain, including its development, vascular disease and tumors. Among these, the Günel lab has expertise in the application of next generation genomic technologies to study the genetic and epigenetic causes of brain and central nervous system tumors, focusing on meningiomas with various histological and pathological grades. Günel lab integrates multilevel approaches including whole exome and whole genome sequencing, molecular inversion probe sequencing (MIPS), whole genome genotyping, array based gene expression, RNA sequencing, whole genome methylation and chromatin immunoprecipitation sequencing (ChIP-seq), followed by downstream biological studies to comprehensively analyze these tumors. The long-term goal of this approach is to define the molecular make-up of these tumors, which will then guide the development of novel therapies, including oncolytic viruses.  In 2015, Dr. Günel was elected to the National Academy of Medicine, the highest distinction in medical sciences. He is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS), both who collectively honored him in 2022 as the fourth recipient of the prestigious Ralph G. Dacey Medal for Outstanding Cerebrovascular Research. In 2021, he received the WINN award, given by the Society of Neurological Surgeons to recognize outstanding, continuous commitment to research in the neurosciences by a neurological surgeon. Dr. Günel previously served as chair of the AANS/CNS Cerebrovascular Section in 2011 and has been elected to the Society of Neurological Surgeons and Academy of Neurological Surgeons. Dr. Günel has been recognized by the Turkish Academy of Arts and Sciences for Outstanding Achievement in Health and Life Sciences and by Kadir Has University for Outstanding Scientific Achievement in Neurosciences.
    • William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology; Chair, Neurology; Neurologist-in-Chief, Yale New Haven Hospital

      Dr. Hafler is the William S. and Lois Stiles Edgerly Professor and Chairman Department of Neurology, Yale School of Medicine and is the Neurologist-in-Chief of the Yale-New Haven Hospital. He graduated magna cum laude in 1974 from Emory University with combined B.S. and M.Sc. degrees in biochemistry, and the University of Miami School of Medicine in 1978. He then completed his internship in internal medicine at Johns Hopkins followed by a neurology residency at Cornell Medical Center-New York Hospital in New York. Dr. Hafler received training in immunology at the Rockefeller University then at Harvard where he joined the faculty in 1984. He was one of the Executive Directors of the Program in Immunology at Harvard Medical School and was on the faculty of the Harvard-MIT Health Science and Technology program where he was actively involved in the training of graduate students and post-doctoral fellows. Hafler, in many respects, is credited with identifying the central mechanisms underlying the likely cause of MS. His early seminal work demonstrated that the disease began in the blood, not the brain, which eventually led to the development of Tysabri to treat the disease by blocking the movement of immune cells from the blood to the brain. He was the first to identify myelin-reactive T cells in the disease, published in Nature, showing that indeed, MS was an autoimmune disorder. He then went on to show why autoreactive T cells were dysregulated by the first identification of regulatory T cells in humans followed by demonstration of their dysfunctional state in MS. As a founding, Broad Institute associate member, Hafler identified the genes that cause MS, published in the New England Journal of Medicine and Nature. More recently, he identified the key transcription factors and signaling pathways associated with MS genes as potential treatment targets. Finally, he recently discovered that salt drives induction of these pathogenic myelin reactive T cells, both works published in Nature. Hafler was the Breakstone Professor of Neuroscience at Harvard, and became Chairman of Neurology at Yale in 2009, where he has built an outstanding clinical and research program that strongly integrates medical sciences. Hafler is among the most highly cited living neurologists and has received numerous honors including the Dystel Prize from the AAN for his MS research, the Raymond Adams Award from the ANA, and was the recipient of the NIH Javits Investigator Award, and The Dale McFarlin Prize by the International Society of Neuroimmunology. He is a member of AOA, the American Society of Clinical Investigation, and was elected into the National Academy of Medicine.
    • Professor of Urology; Professor, Urology; Chair, Urology; Chief, Urology

      Dr. Isaac Kim is a urologic oncologist and surgeon who specializes in the treatment, management, and prevention of prostate cancer, with the goal of helping patients navigate and better understand their disease.  He has expertise in minimally invasive robotic surgery and has completed more than 2,100 robotic surgeries for prostate cancer. Dr. Kim's surgical focus has been on advanced and metastatic prostate cancer, as well as recurrent disease after radiation. Dr. Kim’s clinical research is focused on mechanisms of treatment resistance and specifically immunosuppressive factors produced by prostate cancer cells.  He also has a strong interest in inflammation in prostate cancer and the role of surgery in men with advanced or metastatic prostate cancer.
    • Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry, of Neuroscience, and of Psychology; Co-Director, Yale Center for Clinical Investigation; Chair, Psychiatry; Chief of Psychiatry, Yale-New Haven Hospital; Director: NIAAA Center for the Translational Neuroscience of Alcoholism; Director, Clinical Neuroscience Division, VA National Center for PTSD

      Dr. Krystal is a leading expert in the areas of alcoholism, post-traumatic stress disorder, schizophrenia, and depression. His work links psychopharmacology, neuroimaging, molecular genetics, and computational neuroscience to study the neurobiology and treatment of these disorders. He is best known for leading the discovery of the rapid antidepressant effects of ketamine in depressed patients.He is a member of the U.S. National Academy of Medicine. He also serves in a variety of advisory and review capacities for NIAAA, NIMH, Wellcome Trust, Brain and Behavior Research Foundation, the Broad Institute, the Karolinska Institutet, and the U.S. Department of Veterans Affairs.Dr. Krystal previously served on the National Alcohol Abuse and Alcoholism Advisory Council (NIAAA), the Department of Defense Psychological Health Advisory Committee, the National Institute of Mental Health (NIMH) Advisory Council, and the NIMH Board of Scientific Counselors (chair, 2005-2007). He has led the American College of Neuropsychopharmacology (president, 2012), and International College of Neuropsychophamacology (president, 2016-2018). Currently, he is co-chair of the Forum on Neuroscience and Nervous System Disorders (NeuroForum) of the National Academies of Sciences, Engineering, and Medicine, and he edits the journal, Biological Psychiatry (impact factor: 13.382).
    • Professor of Orthopaedics & Rehabilitation; Chair, Orthopaedics & Rehabilitation; Chief, YNHH

      Dr. Lisa Lattanza is the chair of the Department of Orthopaedics and Rehabilitation at the Yale School of Medicine. She obtained her medical degree at the Medical College of Ohio (now the University of Toledo College of Medicine and Life Sciences). She did her internship at the Harbor-UCLA Medical Center, completed her residency in orthopaedic surgery at the University of Missouri Kansas City and did a fellowship in hand surgery at Columbia College of Physicians and Surgeons/Roosevelt Hospital. She did additional fellowship training in pediatric hand and upper extremity at Texas Scottish Rite Hospital for Children in Dallas, Texas. She joined the faculty of UCSF in 1999. Although Lattanza treats all conditions and traumatic injuries in the upper extremity, she specializes in post-traumatic and congenital reconstruction for pediatric and adult elbow problems, treating patients from around the country and across the globe. She is a world- renowned leader in patient-specific 3D surgical planning and technology for deformity correction. She utilized her expertise in this area when she led a team to perform the first elbow-to-elbow transplant in the world in 2016, transplanting a patient’s left elbow into his right arm to give him one functioning extremity after a devastating accident. Using 3D computing, she also pioneered a new classification system and approach to the treatment of Chronic Monteggia Fracture Dislocations in children. Lattanza frequently travels to Nicaragua and other countries on mission trips to perform hand surgery and is eager to expand upon the global initiatives already in place in the department. Lattanza’s research interests include 3D surgical planning for deformity correction, elbow instability and other post-traumatic elbow conditions in children and adults, and diversity in orthopaedic surgery, specifically the underrepresentation of women. When she began her appointment at the School of Medicine in September 2019, she became one of only two current female chairs of orthopaedics in the U.S. In 2009, she co-founded the Perry Outreach Program to increase exposure of high school girls to orthopaedic surgery and biomechanical engineering. Now known as the Perry Initiative, the program is named after Lattanza’s mentor, Jacquelin Perry, MD, who was one of the first women orthopaedic surgeons in the country. It began with 18 high school girls in San Francisco and has now reached over 10,000 high school, college, and medical students across the country. Lattanza’s research has shown that young women who complete the program are applying and matching to orthopaedic surgery residencies at a rate of about 24%, compared to the national average of about 14%. Her goal is to reach 30% within the next three years. Lattanza has received numerous awards for both her clinical care and outreach efforts. She received UCSF’s Compassionate Physician award in 2013 and Exceptional Physician Award in 2014, the Jefferson Award for Community Service in 2014, and has been ranked by her peers as a Bay Area Top Physician for multiple years. In addition to her other leadership roles, she served as president of the Ruth Jackson Orthopaedic Society in 2017 and is active in the American Academy of Orthopaedic Surgeons, the American Society for Surgery of the Hand, and the American Orthopaedic Association.
    • Nicholas Greene Professor of Anesthesiology; Chair, Anesthesiology

      Dr. Leffert is the Chair of the Yale University School of Medicine and Chief of Anesthesiology at Yale New Haven Hospital and Bridgeport Hospital. Dr. Leffert is nationally and internationally recognized as a clinical expert in obstetric anesthesia and the management of pregnant patients with complex comorbid neurologic and substance use disorders.  She recently served as President of the Society for Obstetric Anesthesia & Perinatology (SOAP), reflecting her subspeciality area of concentration. As SOAP President (2019-2020), she led a governance restructure of the Board and its committees to enhance the diversity, inclusion and the quality of its officers and to professionalize their communications and inter-society collaborations and strengthen their ability to execute their mission. Dr. Leffert does research in neurologic disease and vulnerabilities in pregnant women, and has published original research, reviews, and interdisciplinary guidelines on this topic. She lectures on diverse topics such as peripartum stroke, the anesthetic management of patients with intracranial lesions, strategies for placing neuraxial anesthetics in patients with comorbidities, and the peri-delivery care of patients with substance use disorder.
    • Anthony N. Brady Professor of Pathology; Chair, Pathology; Chief of Pathology, YNHH, Pathology

      Dr. Liu is an expert in viral hepatitis, liver cancer immunotherapy, graft-versus-host disease, and cancer epigenetics. Dr. Liu is Chair of the Department of Pathology and Chief of Pathology at Yale New Haven Hospital. After obtaining his medical degree at Tong Liao Medical College at Inner Mongolia University of Nationality and completing his postgraduate training at Peking Union Medical College in China, Liu received his PhD in pathology from the University of Pennsylvania School of Medicine. He completed his residency in anatomical and clinical pathology at Medical College of Pennsylvania, held an oncological pathology fellowship at M.D. Anderson Cancer Hospital, and had postdoctoral training at Scripps Clinic. Before his appointments at Rutgers in 2015, he was professor and vice chair of pathology, immunology, and laboratory medicine at the University of Florida, where he also held an endowed chair in gastrointestinal and liver research.
    • Arnold Gesell Professor of Child Psychiatry, Pediatrics and Psychology in the Yale Child Study Center; Chair, Child Study Center

      Dr. Linda Mayes is the Arnold Gesell Professor of Child Psychiatry, Pediatrics, and Psychology and Director of the Yale Child Study Center. She is also Special Advisor to the Dean in the Yale School of Medicine. Trained as a pediatrician, Dr. Mayes’s research focuses on stress-response and regulatory mechanisms in young children at both biological and psychosocial risk. She has especially focused on the impact of prenatal substance use on children’s long-term outcomes. She has made contributions to understanding the mechanisms of effect of prenatal stimulant exposure on the ontogeny of arousal regulatory systems and the relation between dysfunctional emotional regulation and impaired prefrontal cortical function in young children. She has published widely in the developmental psychology, pediatrics, and child psychiatry literature. Given the nature of her work with children at significantly high-risk for developmental impairments from both biological and psychosocial etiologies, Dr. Mayes also focuses on the impact of parenting on the development of arousal and attention regulatory mechanisms in their children, and specifically on how substance abuse impacts reward and stress regulatory systems in new parents. With other colleagues in the Center, she studies how adults transition to parenthood, especially when substance abuse is involved, and the basic neural circuitry of early parent-infant attachment using both neuroimaging and electroencephalographic techniques. She and her colleagues have developed a series of interventions for parents including an intensive home-based program called Minding the Baby. Dr. Mayes's research programs are multidisciplinary, not only in their blending basic science with clinical interventions but also in the disciplines required including adult and child psychiatry, behavioral neuroscience, obstetrics, pediatrics, and neuropsychology. She is also a Distinguished Visiting Professor in psychology at Sewanee: The University of the South where she is working on intervention programs to enhance child and family resilience.
    • Professor of Laboratory Medicine, of Biomedical Engineering, of Medicine (Hematology) and of Pediatrics; Deputy Dean for Research, (Clinical and Translational); Co-Director, Yale Center for Clinical Investigation (YCCI); Director, Clinical Immunology Laboratory, Laboratory Medicine; Chair, Laboratory Medicine; Chief, Laboratory Medicine

      Brian R. Smith MD is Deputy Dean for Clinical and Translational Research at the Yale School of Medicine, as well as Co-Director of the Yale Center for Clinical Investigation (Co-PI of Yale's CTSA Award), Chair of the Department of Laboratory Medicine and Professor of Laboratory Medicine, Biomedical Engineering, Internal Medicine and Pediatrics at Yale University. He is the Chief of Laboratory Medicine and Attending Physician at Yale New Haven Hospital and also an attending physician at the Connecticut VA Medical Center and the Bridgeport Hospital.Dr. Smith received his undergraduate degree summa cum laude from Princeton University, his medical degree from the Harvard Medical School, and his residency/fellowship training at The Brigham & Women’s Hospital, Boston Children’s Hospital, and Dana Farber Cancer Center. He is board certified in Pathology / Hematopathology and in Internal Medicine / Hematology-Oncology. In addition to his clinical work, Dr. Smith has an investigative interest in the inflammation-hemostasis interface, especially in relation to biomaterials, as well as in cellular immunotherapeutics, with over 175 publications. His work extends from basic wet bench research through clinical and epidemiological trials (T1-T4). He has been continuously funded by the NIH at the PI-level for over 35 years. In these various roles, Dr. Smith has major administrative responsibility for the School’s research enterprise across the T1-T4 spectrum, as well as educational responsibilities across the scientific pipeline from STEM high school student programs through undergraduate, graduate, and post-graduate training, for MDs, PhDs, and MD/PhDs. He is the initiator and long-standing PI of Laboratory Medicine’s post-doctoral T32 training program in Immunohematology and has personally mentored over 50 MD, MD/PhD, and PhD trainees, most of whom hold tenure-track positions at major research universities. In addition to directing trainees in bench and translational research, Dr. Smith has extensive experience in the didactic aspects of comprehensive training and career development for clinician-scientists, having developed and published curricula in Laboratory Medicine, developed and published new physician-scientist training paradigms in his field, and, in his capacity as the Chair of the Research Committee for the Association of Pathology Chairs, initiated and helped negotiate a dialogue with the American Board of Pathology that, with the work of many other Chairs of Pathology and Laboratory Medicine, resulted in the adoption of a specific Physician-Scientist residency pathway by the Board. Similarly, through his research experience, dean position, and appointment in the Graduate School of Arts and Sciences, he is very involved with all aspects of PhD training at both the pre- and post-doctoral levels. He has been an invited lecturer on Bioethics and previously served on the NIH Recombinant DNA Advisory Committee. Dr. Smith has also played a significant role in gender equity initiatives at Yale. In addition, he has overseen the implementation of research core facilities in Translational Immune Monitoring, Flow Cytometry, and Clinical Sample Real Time Acquisition, chairs the Clinical Research Technology Committee, and has been a guiding member of a Cellular Therapy core resource, all of which have been used successfully by Yale investigators as well as by investigators from other universities.
    • Anita O'Keeffe Young Professor of Obstetrics, Gynecology, and Reproductive Sciences and Professor of Molecular, Cellular, and Developmental Biology; Chair, Obstetrics, Gynecology & Reproductive Sciences; Chief of Obstetrics and Gynecology, Yale-New Haven Hospital

      Dr. Taylor is the Anita O'Keeffe Young Professor and Chair, Department of Obstetrics Gynecology and Reproductive Sciences at Yale School of Medicine and Chief of Obstetrics and Gynecology at Yale-New Haven Hospital. He is also Professor of Molecular, Cellular and Developmental biology at Yale University. His clinical interests include IVF, infertility, endometriosis, implantation, menopause, uterine anomalies and Asherman's syndrome. Dr. Hugh Taylor received his undergraduate training at Yale University and received his medical degree from the University of Connecticut School of Medicine. He completed his residency in Obstetrics and Gynecology at Yale. His postdoctoral training included a fellowship in Reproductive Endocrinology and Infertility as well as a fellowship in Molecular Biology, both at Yale. Dr. Taylor is a board certified specialist in Obstetrics and Gynecology and in Reproductive Endocrinology. His clinical research centers on endometriosis and fibroids. His basic science research focuses on uterine development, endometriosis, endocrine disruption, and on stem cells. He is a recipient of ten National Institutes of Health research grants and directs The Yale Center for Reproductive Biology. Dr. Taylor has published more than 400 articles and in leading medical journals.  He has served as president of the Society for Reproductive Investigation and president of the American Society for Reproductive Medicine in 2021.  He is a member of the National Academy of Medicine.
    • Alfred Gilman Professor of Pharmacology and Professor of Medicine (Medical Oncology); Director, Yale Cancer Center; Physician-in-Chief, Smilow Cancer Network; Alfred Gilman Professor, Medicine and Pharmacology

      Dr. Eric Winer is the Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Network as of February 1, 2022.  An internationally renowned expert in breast cancer, Dr. Winer has led and collaborated on innumerable clinical trials that have changed the face of the disease.  His work is both broad and deep, and it has touched almost all aspects of breast cancer.  Dr. Winer has long been an advocate of building teams consisting of scientists and clinicians to accelerate progress in cancer research and care. Dr. Winer is President of the American Society of Clinical Oncology (ASCO) and a member of the Scientific Advisory Board of the Breast Cancer Research Foundation. For over a decade, he served as chief scientific advisor and chair of the Scientific Advisory Board for Susan G. Komen for the Cure. For the past six years he has co-led the National Cancer Institute Breast Cancer Steering Committee.  Dr. Winer has published over 350 original manuscripts and mentored over 30 fellows and junior faculty. In recognition of his mentoring impact, he was the recipient of the William Silen Lifetime Achievement in Mentoring Award from Harvard Medical School in 2020.  He has also received numerous awards for his breast cancer research, most notably the William L. McGuire Memorial Lecture Award in 2016 at the San Antonio Breast Cancer Symposium.Dr. Winer is an alumnus of both Yale College and Yale School of Medicine. After receiving his medical degree in 1983, he completed training in internal medicine and served as chief resident at Yale New Haven Hospital. He completed a fellowship in hematology/oncology at Duke University School of Medicine and served on the Duke faculty from 1989 to 1997.  He then joined Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Harvard Medical School where he has spent the last 24 years.  Most recently, he held the Thompson Chair in Breast Cancer Research and served as chief clinical development officer, and senior vice president for medical affairs at Dana-Farber Cancer Institute, as well as Professor of Medicine at Harvard Medical School.
  • At-large Board Members

    • Professor of Pathology and of Medicine (Digestive Diseases); Director, Program in Gastrointestinal and Liver Pathology, Pathology

      Dr. Robert is a gastrointestinal, liver and pancreaticobiliary surgical pathologist. She completed her undergraduate and medical school education at the University of Michigan, followed by residency training in Anatomic and Clinical Pathology and a fellowship in gastrointestinal pathology at the University of California, Los Angeles. She was an assistant professor at the University of California, San Francisco, specializing in liver transplant pathology prior to joining the Department of Pathology at Yale University School of Medicine in 1994. Dr. Robert served as the Director of the Program in Gastrointestinal Pathology and the Director of the Fellowship in Gastrointestinal Pathology for over ten years. In addition to extensive clinical activities, Dr. Robert participates in clinical and translational research, and collaborates with scientists in the basic sciences at Yale School of Medicine. Her research interests include liver transplantation, inflammatory bowel diseases, celiac disease, stromal responses in pancreatic cancer and colitis induced by immune therapies, such as immune checkpoint inhibitors.
    • Associate Professor of Medicine (AIDS); HIV / AIDS Care Program Director, Infectious Diseases; Donaldson Firm Chief, Infectious Diseases

      Dr. Villanueva is Director of the HIV/AIDS Program and Associate Professor of Medicine at Yale University School of Medicine. She obtained her undergraduate degree at Harvard University and MD at Washington University. She completed Internal Medicine Residency training at Duke University and subspecialty fellowship training in Infectious Diseases at Yale.After fellowship, she left academia to work at Waterbury Hospital, a community hospital, where she was Chief of Infectious Diseases. During this time, she established the Ryan White-funded HIV clinic which worked closely with community based AIDS organizations. Her experience in promoting collaborations became the basis for subsequent research interests and her recruitment back to Yale.A major focus of her academic work has been on developing HIV educational curricula for medical providers including Yale house staff and community providers throughout CT. She also serves as the Principal Investigator for the New Haven Ryan White HIV Continuum, a collaboration between different clinics and community organizations which promotes service coordination to improve quality of care for HIV patients, particularly those that are underserved. Her research interests focus on optimizing models of care that capitalize on partnerships between the medical establishment and community support.
  • Yale Medicine Learning Academy Team

  • Yale Medicine Marketing

  • YM Credentialing Committee

    • Chair

      Professor of Obstetrics, Gynecology, and Reproductive Sciences and of Pediatrics; Vice Chair, Department of Obstetrics, Gynecology and Reproductive Sciences; Assistant Dean of Clinical Affairs, Yale Medicine

      As an expert in prenatal diagnosis and fetal therapy, Dr. Copel has pioneered new diagnostic techniques for unborn patients and their mothers. He is also an expert in both surgical and non-invasive approaches to maternal-fetal care. “One of the most rewarding aspects of my particular field is when I really can say we made a difference,” says Dr. Copel. “It’s just great to say this kid wouldn’t be here if not for what we did prenatally.”After completing a residency in Obstetrics & Gynecology at Pennsylvania Hospital, Dr. Copel arrived at YNHH in 1983 to complete a fellowship in Maternal-Fetal Medicine with Yale University School of Medicine. He stayed on to become a professor in two departments at Yale: Ob/Gyn and Pediatrics. Dr. Copel’s clinical interests include fetal echocardiography, chorionic villus sampling (where a small amount of placenta is tested for health risks and chromosomal conditions like Down Syndrome), amniotic fluid testing, and first trimester pregnancy screenings.Dr. Copel is passionate about the high level of care his patients can expect to receive at YNHH, and proud that his team has been able to collaborate with medical societies both across the United States and abroad. “We can reach out with teaching techniques—including teaching about prenatal diagnosis—to large numbers of physicians around the world. What they are going to go and do for their patients is a much broader legacy than just working in a single practice,” he says.
    • Associate Professor of Medicine (Medical Oncology); Disease Aligned Research Team (DART) Leader Sarcoma, Medical Oncology; Director Medical Oncology Inpatient Consult Service, Medical Oncology

      Dr. Hari Deshpande, Associate Professor of Medicine in the Section of Medical Oncology, cares for patients with sarcomas along with the sarcoma multidisciplinary team.Previously in practice at both the New London Cancer Center and Las Vegas Cancer Center, Dr. Deshpande also has clinical interests in sarcomas, cancers of unknown primary, and thyroid cancers. He is a member of the Head and Neck Cancer and GU cancer teams. He is the Director of the Medical Oncology Inpatient Consult service.Learn more about Dr. Deshpande>>
    • Associate Professor of Surgery (Bariatric, Minimally Invasive); Associate Surgical Chief, Digestive Health; Medical Director, Yale New Haven Health System Hernia Program

      Andrew Duffy, MD, is a Board Certified General Surgeon and is fellowship-trained in minimal access surgery. He is the Associate Surgical Chief of the Digestive Health Service line and the Medical Director of the Hernia Center for Yale-New Haven Health System. He offers minimally invasive surgery of the abdomen and GI tract, including laparoscopic and robotic techniques.  His goal is to offer the most effective surgery with the least recovery time and post-operative discomfort.Dr. Duffy is dedicated to helping individuals with acute and chronic issues related to hernias or with their stomach, intestines, gallbladder, or other abdominal organs. He specializes in all type of primary and recurrent abdominal wall. He has extensive experience at surgically treating hernia surgery-related complications, including mesh problems.He also offers minimally invasive techniques for correcting hiatal hernias, GERD, acid reflux, paraesophageal hernias, complications of prior stomach and hiatal hernia surgery, achalasia and other swallowing disorders.He also specializes in laparoscopic and robotic procedures for obesity, including gastric bypass, sleeve gastrectomy, adjustable gastric banding and revision of prior bariatric surgery.He specializes in laparoscopic gastrointestinal surgery; laparoscopic bariatric surgery for morbid obesity; laparoscopic gastric bypass surgery; laparoscopic adjustable gastric banding; laparoscopic sleeve gastrectomy; revisional bariatric surgery; laparoscopic surgery for reflux and achalasia; laparoscopic Nissen, laparoscopic Heller myotomy; laparoscopic splenectomy; laparoscopic paraesophageal hernia repair; laparoscopic repair of abdominal-wall hernias; laparoscopic repair of inguinal hernias; gall bladder; gall stones; cholecystectomy; gall stone pancreatitis; Gastroesophageal Reflux Disease (GERD); gastroparesis. Robotic surgery
    • Senior Research Scientist

      Dr. Duncan graduated from Vanderbilt University in 1968 with a BA degree and received his medical degree from Duke University in 1972. He did his surgical internship from 1971-1972 at Duke and his neurosurgery residency, also at Duke, from 1972-1977. He joined the Yale faculty and the Yale New Haven Hospital staff in 1977. He received his board certification in Neurosurgical Surgery in 1979. In 1978, he became Chief of Pediatric Neurosurgery at Yale and has progressed through the academic ranks at the university to become Professor of Neurosurgery and Pediatrics in 1994. He spent 1985-1986 in Special Studies at the School of Organization and Management Group. He has established the only dedicated pediatric neurosurgical unit in the state, published over 100 articles, and has been the principal investigator or co-investigator in twenty funded research projects. He was the co-principal investigator for the Indomethacin Projects to prevent intraventricular hemorrhage in preterm infants, which has been adopted in over 75 countries. He has served on the Credentials Committee, Operating Room Work Redesign Committee, By-Laws Review, Risk Management and other hospital committees. He is the program director for the Neurosurgery Residency Program. After running one marathon, Dr. Duncan decided he preferred fly-fishing.
    • Associate Professor Adjunct in Pathology; Management Team, Pathology; Director, Residency Program, Pathology; Director, Cytopathology Fellowship Program, Pathology

      Dr. Kowalski is Director of the Anatomic and Laboratory Medicine Residency program at Yale. She is a board-certified in anatomic pathology and cytopathology. She received her M.D. from the Medical College of Georgia, and completed her pathology residency at Hartford Hospital. After completing a cytopathology fellowship at Yale-New Haven Hospital, she joined the faculty at Yale. Areas of interest include head and neck pathology, thyroid cytology, and graduate medical education.
    • Associate Professor of Surgery (Trauma); Director, Surgery Clerkship Program, Yale School of Medicine

      Dr. Lui is board certified in general surgery and in surgical critical care by the American Board of Surgery. His clinical interests include trauma, surgical critical care, emergency and elective general surgery, re-operative surgery, sepsis and resuscitation, and shock. His research interests include shock physiology, resuscitation in trauma, pediatric trauma, and surgical infections, including necrotizing soft tissue infections, surgical education and bioethical issues in medicine.He is certified in and is an instructor of Advanced Trauma Life Support and Advanced Trauma Operative Management. He is also certified in Advanced Cardiac Life Support and Pediatric Advanced Life Support.Dr. Lui earned his undergraduate degrees in Biomedical Ethics and Biology and his medical degree from Brown University. He completed his residency in general surgery at Berkshire Medical Center, University of Massachusetts School of Medicine in Pittsfield, and was fellowship trained in trauma and surgical critical care at R Adams Cowley Shock Trauma Center, University of Maryland Medical School in Baltimore. He is an Associate Professor at Yale School of Medicine Department of Surgery (Trauma).Dr. Lui is a member of the following organizations: Eastern Association for the Surgery of Trauma, Society for Critical Care Medicine, Surgical Infection Society, Association for Surgical Education, Connecticut Committee on Trauma, Connecticut chapter of the American College of Surgeons, and Association for Academic Surgery. He is a Fellow of the American College of Surgeons.
    • Professor; Regional Director, Ambulatory Services, Yale Medicine; Medical Director, Yale Clinical Optimization Service; Director, Pediatric IBD program, Pediatrics

      Dr. Pashankar completed his basic medical training in India and in the UK. He completed fellowship training in Pediatric Gastroenterology at BC Children's Hospital in Vancouver, Canada.  He has MBA in healthcare from Yale School of Management and has expertise in process and quality improvement. His clinical and research interest is in inflammatory bowel disease in children.  He is the director of Yale Pediatric Inflammatory Bowel Disease Program. He runs a multidisciplinary Inflammatory Bowel disease clinic at Yale New Haven Children's Hospital in New Haven. He has published a number of clinical studies in pediatric gastroenterology and inflammatory bowel diseases. He is a medical director of  Yale Clinical Optimization Service and works to improve efficiency in ambulatory operations of Yale Medicine clinical sections in pediatric and adult specialties. He is a regional medical director of Yale Medicine ambulatory services and oversees Yale Medicine clinics in New Haven region.
    • John Slade Ely Professor Emeritus of Obstetrics, Gynecology, and Reproductive Sciences; Vice Chair, Gynecology

      Dr. Peter Schwartz has been a member of the Yale Cancer Center since he joined the Yale School of Medicine Faculty in 1975. He was the first Director of the Division of Gynecologic Oncology, which he formed in 1978, and the first Director of the Gynecologic Oncology Fellowship Training Program, which was approved by the American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology in 1980. Dr. Schwartz has served as President of the New Haven Obstetrical Society, The New England Association of Gynecologic Oncologists, The Felix Rutledge Society and The Society for Gynecologic Oncology. His research has focused on gynecologic cancers and their treatment. He is recognized as an international expert on the management of the rare germ cell malignancies, as well as introducing neoadjuvant chemotherapy into the treatment of the common advanced stage epithelial ovarian cancers which now has been accepted as a standard treatment by the National Comprehensive Cancer Network for the United States. He performed the first prospective randomized trial incorporating hormonal therapy with conventional platinum-based chemotherapy based on laboratory research at Yale identifying estrogen receptor proteins in epithelial ovarian cancers. He reported the first series of gynecologic cancer patients to have massive hemorrhage controlled by selective arteriography and transcatheter embolization, coil placement or balloon catheter placement and subsequently showed these techniques could also be employed to control massive postpartum hemorrhage. His clinical studies on the management of uterine serous cancer established a very successful standard therapy for early stage disease, which previously had been associated with an extremely poor prognosis. He has had a strong interest in the early detection of ovarian cancer and established the Yale Early Detection Program for Ovarian Cancer in 1990, one of the first such programs in the United States. That program was based on prior tumor marker research and diagnostic imaging studies he performed with other collaborators at Yale. Dr. Schwartz is a member of the editorial boards of seven professional journals, has served on numerous Department and Yale Cancer Center committees and currently serves as a member of the Oncology Patient Safety and Quality Council and the Smilow Leadership Council.
    • Associate Professor of Ophthalmology and Visual Science; Director, Retina Fellowship Program

      Dr. Stoessel specializes in Medical Retina and is Director of the Retina Fellowship Program.  She received her MD from the State University of New York/Downstate Medical Center and completed Ophthalmology Residency at the Yale School of Medicine in followed by a Vitreoretinal Fellowship, also at Yale.  Dr. Stoessel joined the Yale Eye Center as a full-time faculty in Retina.  Dr. Stoessel directs the Retinopathy of Prematurity (ROP) program at Yale-New Haven Hospital, in which premature infants have retina evaluations, monitoring, and laser treatment when indicated to lower the risk of vision loss.  Dr. Stoessel is the Retina Co-investigator at Yale for the Epidemiology of Diabetes Interventions and Complications (EDIC) Trial.  Her clinical interests lie in the evaluation and laser treatment of ROP and other adult and pediatric proliferative retinopathies, sickle cell retinopathy, retinal evaluation in pediatric head trauma, diabetic retinopathy, macular degeneration, retinal dystrophies.
  • Yale Medicine Compliance

  • Yale Medicine Compliance Leaders

    • Compliance Medical Director

      Professor of Obstetrics, Gynecology, and Reproductive Sciences and of Pediatrics; Vice Chair, Department of Obstetrics, Gynecology and Reproductive Sciences; Assistant Dean of Clinical Affairs, Yale Medicine

      As an expert in prenatal diagnosis and fetal therapy, Dr. Copel has pioneered new diagnostic techniques for unborn patients and their mothers. He is also an expert in both surgical and non-invasive approaches to maternal-fetal care. “One of the most rewarding aspects of my particular field is when I really can say we made a difference,” says Dr. Copel. “It’s just great to say this kid wouldn’t be here if not for what we did prenatally.”After completing a residency in Obstetrics & Gynecology at Pennsylvania Hospital, Dr. Copel arrived at YNHH in 1983 to complete a fellowship in Maternal-Fetal Medicine with Yale University School of Medicine. He stayed on to become a professor in two departments at Yale: Ob/Gyn and Pediatrics. Dr. Copel’s clinical interests include fetal echocardiography, chorionic villus sampling (where a small amount of placenta is tested for health risks and chromosomal conditions like Down Syndrome), amniotic fluid testing, and first trimester pregnancy screenings.Dr. Copel is passionate about the high level of care his patients can expect to receive at YNHH, and proud that his team has been able to collaborate with medical societies both across the United States and abroad. “We can reach out with teaching techniques—including teaching about prenatal diagnosis—to large numbers of physicians around the world. What they are going to go and do for their patients is a much broader legacy than just working in a single practice,” he says.
    • Professor of Surgery (General, Trauma & Surgical Critical Care); Chief of the Division of General Surgery, Trauma, and Surgical Critical Care, Surgery; Vice Chairman, Clinical Affairs, Department of Surgery; Trauma Medical Director, Yale-New Haven Hospital; Surgical Director, Performance and Quality Improvement, Yale-New Haven Hospital

      Dr. Davis is Professor of Surgery and Vice Chairman for Clinical Affairs at the Yale School of Medicine Department of Surgery.  She is the Chief of the Division of General Surgery, Trauma and Surgical Critical Care at Yale, as well as the Trauma Medical Director for Yale New Haven Hospital, an American College of Surgeons verified and Connecticut Department of Health designated Level One Trauma Center for both adult and pediatric patients.  Dr. Davis also serves as the Surgical Director of Quality and Performance Improvement for Yale-New Haven Hospital and formerly as the NSQIP Surgeon Champion.  After earning a BS in Molecular Biophysics and Biochemistry at Yale, she attended Albany Medical College and received her surgical training from the Brown University/Rhode Island Hospital program.  Following a fellowship in trauma and surgical critical care at the University of Tennessee - Memphis, she spent eight years on the faculty at Loyola University Medical Center in Illinois prior to returning to Yale in 2006.  Dr. Davis received her MBA from the Yale School of Management Leadership in Healthcare program in 2012.  She serves on the National Committee on Trauma, is the immediate Past-President of the Connecticut chapter of the American College of Surgeons and recently retired from the Board of Governors.  She is the Secretary Treasurer of the American Association for the Surgery of Trauma, Past President of the Eastern Association for the Surgery of Trauma and the former Chief of Region I for the Committee on Trauma.  She has held leadership positions in several other regional and national organizations.  She has published extensively in medical literature, with over 180 peer reviewed publications.  She is an Associate Editor of Trauma Surgery and Acute Care Open, serves on the editorial boards of the Journal of Trauma and Acute Care Surgery, the Journal of Burn Care and Rehabilitation and Current Trauma Reports, and is an ad hoc reviewer for 10 other critical care and surgical journals.   Dr. Davis is board certified in surgery and surgical critical care. Her research interests are in the fields of performance improvement and quality, inflammation and sepsis, and trauma resuscitation.
    • Associate Professor of Medicine (Medical Oncology); Disease Aligned Research Team (DART) Leader Sarcoma, Medical Oncology; Director Medical Oncology Inpatient Consult Service, Medical Oncology

      Dr. Hari Deshpande, Associate Professor of Medicine in the Section of Medical Oncology, cares for patients with sarcomas along with the sarcoma multidisciplinary team.Previously in practice at both the New London Cancer Center and Las Vegas Cancer Center, Dr. Deshpande also has clinical interests in sarcomas, cancers of unknown primary, and thyroid cancers. He is a member of the Head and Neck Cancer and GU cancer teams. He is the Director of the Medical Oncology Inpatient Consult service.Learn more about Dr. Deshpande>>
    • Senior Director, Finance & Administration; Deputy Director, Finance & Administration

      Margaret is Deputy Director for Finance & Administration for Yale Cancer Center. Margaret first joined Yale Cancer Center a year ago as Senior Director of Finance & Administration, while also leading the Integrated Business Operations for the Department of Pathology.As Deputy Director for Finance & Administration for Yale Cancer Center, Margaret oversees the management of the clinical operations, business operations and finance, administration, research management, and clinical trials management for Yale Cancer Center. Prior to her work with Pathology, Margaret also served in similar roles for the Departments of Orthopedics and Rehabilitation and Emergency Medicine at Yale School of Medicine. Before joining Yale, Margaret spent 14 years in administrator and clinical leadership roles at the University of Washington School of Medicine in Seattle.
    • Professor of Radiology and Biomedical Imaging; Chair, Radiology and Biomedical Imaging; Radiologist-in-Chief, Yale New Haven Health

      Rob Goodman, MB BChir, MBA is the Chair of the Department of Radiology & Biomedical Imaging at Yale School of Medicine, Chief of Radiology at Yale New Haven Hospital and Radiologist-in-Chief at Yale New Haven Health System.Dr. Goodman joined Yale in 2004 from the John Radcliffe Hospital in Oxford, UK, where he was lead clinician for its radiology department. He obtained his medical degree from Cambridge University in 1988 and an MBA in Healthcare from Yale in 2017. Upon completing his residency at the Central Oxford Hospitals in the UK, he did a fellowship in pediatric radiology at The Hospital for Sick Children in Toronto. After his relocation from Europe to the United States, he was struck by the marked differences in radiation awareness between the two countries, which is particularly relevant in pediatric radiology due to children’s susceptibility to the effects of radiation. He subsequently played a major role in the movement to reduce radiation exposure from CT scans in children, as well as adults. As a way to reduce radiation exposure, his clinical interests also included improved utilization of ultrasound in pediatric imaging. He has published and lectured on these topics nationally and is the Pediatric Community of Practice President for the American Institute for Ultrasound in Medicine, and sits on its Board of Governors. He has been involved in developing national consensus guidelines for such topics as neonatal echoencephalography, pediatric spinal ultrasound, hip ultrasound, and imaging in pregnant patients. During his tenure at Yale, Dr. Goodman has overseen the expansion of pediatric radiology services, spearheaded the installation of a dedicated pediatric MRI scanner at Yale New Haven Children’s Hospital, implemented a critical test result reporting system, and identified mechanisms to improve the radiology peer review process. He recently helped execute an imaging industry relationship with Siemens Healthcare for Yale New Haven Health System. As Chair, Dr. Goodman is building upon the department’s clinical strengths and world-class research taking place in such areas as novel MR pulse sequences, functional MRI, MR spectroscopy, novel PET tracers, and advanced image processing. By including industry partners, he is eager to expand its translational research program to help convert basic science discoveries into clinical applications that improve patient care.
    • Professor Adjunct, Neurology

      Dr. Greer received his MD and MA (English Literature) from the University of Florida, and then trained at the Massachusetts General Hospital in neurology, with specialized fellowship training in stroke and neurocritical care. His special interests include coma and disorders of consciousness, ischemic stroke, and neurocritical care._
    • Associate Professor of Pediatrics; Director, Pediatric Heart Transplant Program, Pediatric Cardiology; Director, Pediatric Heart Failure and Cardiomyopathy Program, Pediatric Cardiology

      2006 - 2009 Fellowship, Pediatric Cardiology, Children's Hospital of Philadelphia2009 - 2010 Senior Fellowship, Heart Failure & Transplant, Children's Hospital Boston
    • Professor of Pathology and of Medicine (Digestive Diseases)

      Dr. Dhanpat Jain is a Professor of Pathology and Internal Medicine (section of Digestive Diseases). Dr. Jain graduated from Mysore Medical College, Mysore, India and received his M.B.B.S degree in 1986. He subsequently received his M.D. Pathology degree from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India in 1991. He moved to the U.S. in 1995 and completed his Anatomic Pathology residency and Fellowship in Gastrointestinal Pathology at Yale University School of Medicine, and subsequently continued as a faculty there.Dr. Jain is a nationally and internationally recognized gastrointestinal pathologist known for his diagnostic skills, research and teaching. He has more than 150 publications, many book chapters, books and reviews, all of which are largely in the field of gastrointestinal and liver pathology. He has delivered many lectures and participated in many courses at the national and international level. He is on the editorial board of several high impact journals in the field of gastrointestinal and liver disorders. His area of expertise is motility disorders of the gastrointestinal tract, for which he gets cases in consultation from across the globe. Dr. Jain is an accomplished teacher and has received many awards. He has continuously been nominated for “Best Doctors in America” for many years.
    • Associate Professor and Vice Chair of Faculty Affairs, Orthopaedics & Rehabilitation; Head Team Physician & Head Orthopaedic Surgeon WNBA CT Sun Women's basketball team, Yale Orthopaedics

      Dr. Medvecky joined the faculty of Yale Orthopaedics 2001 after completing his subspecialty fellowship training in orthopaedic sports medicine, arthroscopy and reconstructive knee & shoulder surgery at Cincinnati Sportsmedicine & Orthopaedic Center. Under the direction of Frank Noyes, MD, an internationally recognized authority on complex knee injuries & conditions, he gained experience in diagnosing and treating the most complicated conditions that sports medicine surgeons will face. Prior to this training, he completed his internship and residency in Manhattan at NYU-Bellevue Hospital Medical Center and New York University-Hospital for Joint Diseases Orthopaedic Institute, respectively.Since starting practice, he has also been an active participant in the Yale-New Haven Hospital Level-1 Orthopaedic Trauma Service, assisting in the care of poly-traumatized patients. His coupled interests in sports medicine and orthopaedic trauma have given him experience in the evaluation and treatment of complex knee and shoulder injuries and he utilizes both arthroscopic and open approaches to treat ligament, meniscus and articular cartilage injuries, based upon biomechanical and anatomical principles and proven clinical studies.Dr. Medvecky serves as the Head Team Physician & Head Orthopedic Surgeon for both the WNBA Connecticut Sun and the New England Blackwolves men’s indoor lacrosse, based at the Mohegan Sun Arena in Uncasville, CT. He is also a consultant orthopaedist to the Yale University Athletic teams. He has also played an active role in regional athletic event coverage and continues to voluntarily serve the New Haven Road Race for over 15 years. He previously had served as Head Tournament physician for the WTA Connecticut Open tennis tournament, until its departure from New Haven in 2019. Dr. Medvecky has been an active participant in graduate medical education and received the University Faculty Teaching Award for his contribution to the Yale-New Haven Hospital orthopaedic residency education. He has established an annual post-graduate medical education course to teach practicing primary care physicians how to best evaluate & treat musculoskeletal conditions seen in their practice. In his efforts to promote health and safety in youth and adult athletics, he also serves on the CT State Medical Society’s Committee on the Medical Aspects of Sports.
    • Lead Administrator for FAS Divisions of Humanities, Social Sciences and Academic Services

      Theresa is currently the Administrator of the Department of Emergency Medicine Business Office. She first came to Yale in 1980. She spent the last three and a half years on the central campus initially as a participant in the career development program offered through the Shared Science Service Branch and then went on to become the Business manager for the Department of Astronomy. Prior to transferring to the central campus, Theresa was the Clinical Practice Manager for the Departments of Pediatrics and Surgery and held clinical roles in the Department of Orthopaedics and PFS. Theresa received her Bachelor of Science degree in Business Management from Albertus Magnus College.
    • George D. and Esther S. Gross Professor Emeritus of Psychiatry

      Dr. Sledge has served in a variety of roles within Psychiatry as well as Yale University. Within Psychiatry, he was Clinical Director of the Connecticut Mental Health Center until he moved in 1996 to the Medical Directorship of Psychiatry at Yale New Haven Hospital. From 1995 to 2005, he was also Master of Calhoun College and participated in a variety of administrative roles in Yale College including Chair of the Council of Masters. He is a psychoanalyst as well as a health services investigator and innovator of clinical services.
    • Associate Professor of Ophthalmology and Visual Science; Director, Retina Fellowship Program

      Dr. Stoessel specializes in Medical Retina and is Director of the Retina Fellowship Program.  She received her MD from the State University of New York/Downstate Medical Center and completed Ophthalmology Residency at the Yale School of Medicine in followed by a Vitreoretinal Fellowship, also at Yale.  Dr. Stoessel joined the Yale Eye Center as a full-time faculty in Retina.  Dr. Stoessel directs the Retinopathy of Prematurity (ROP) program at Yale-New Haven Hospital, in which premature infants have retina evaluations, monitoring, and laser treatment when indicated to lower the risk of vision loss.  Dr. Stoessel is the Retina Co-investigator at Yale for the Epidemiology of Diabetes Interventions and Complications (EDIC) Trial.  Her clinical interests lie in the evaluation and laser treatment of ROP and other adult and pediatric proliferative retinopathies, sickle cell retinopathy, retinal evaluation in pediatric head trauma, diabetic retinopathy, macular degeneration, retinal dystrophies.
    • Professor of Therapeutic Radiology and of Dermatology; Executive Vice Chairman; Deputy Chief Medical Officer, Therapeutic Radiology; Director of Clinical Affairs; Clinical Program Leader, Therapeutic Radiology, Yale Cancer Center; Associate Director of the Residency Training Program, Therapeutic Radiology

      Lynn Wilson, MD, MPH, Executive Vice Chairman and Director of Clinical Affairs of Yale Medicine’s Therapeutic Radiology Department, cares for patients with cutaneous lymphoma and breast cancer at Smilow Cancer Hospital at Yale New Haven. As a board-certified radiation oncologist, Dr. Wilson’s primary goal is to successfully treat his patients while limiting side effects from radiation treatment. “This can be best achieved through multidisciplinary collaboration among specialists focused on the patient,” he says.Through the use of specialized techniques, Dr. Wilson and his colleagues have been able to provide substantial pain relief (also called palliative care) for those in need, enhancing their quality of life. “Yale is both a national and international destination medical center for patients with cutaneous lymphoma,” he explains. “Our total skin electron beam therapy program is recognized as a major, national program anchored by a team with significant international expertise.”In addition to providing clinical care, Dr. Wilson is also a professor of therapeutic radiology and dermatology. He studies outcomes and treatment-related factors for patients receiving care for cutaneous lymphoma, lung and breast cancers.For example, new research reveals that there may be disparities in clinical outcomes for cutaneous lymphoma based on race. “This is a significant finding,” explains Dr. Wilson. “We are working toward understanding why this may be the case, so that we can address these issues for our patients.”Dr. Wilson serves on the board of trustees for the American Board of Radiology and is a member of the American Society for Radiation Oncology board of directors.
  • Yale Medicine Compliance Committee

    • Professor of Obstetrics, Gynecology, and Reproductive Sciences and of Pediatrics; Vice Chair, Department of Obstetrics, Gynecology and Reproductive Sciences; Assistant Dean of Clinical Affairs, Yale Medicine

      As an expert in prenatal diagnosis and fetal therapy, Dr. Copel has pioneered new diagnostic techniques for unborn patients and their mothers. He is also an expert in both surgical and non-invasive approaches to maternal-fetal care. “One of the most rewarding aspects of my particular field is when I really can say we made a difference,” says Dr. Copel. “It’s just great to say this kid wouldn’t be here if not for what we did prenatally.”After completing a residency in Obstetrics & Gynecology at Pennsylvania Hospital, Dr. Copel arrived at YNHH in 1983 to complete a fellowship in Maternal-Fetal Medicine with Yale University School of Medicine. He stayed on to become a professor in two departments at Yale: Ob/Gyn and Pediatrics. Dr. Copel’s clinical interests include fetal echocardiography, chorionic villus sampling (where a small amount of placenta is tested for health risks and chromosomal conditions like Down Syndrome), amniotic fluid testing, and first trimester pregnancy screenings.Dr. Copel is passionate about the high level of care his patients can expect to receive at YNHH, and proud that his team has been able to collaborate with medical societies both across the United States and abroad. “We can reach out with teaching techniques—including teaching about prenatal diagnosis—to large numbers of physicians around the world. What they are going to go and do for their patients is a much broader legacy than just working in a single practice,” he says.
    • Vice Provost for Faculty Development and Diversity; Chair, Department of Internal Medicine; and Paul B. Beeson Professor of Medicine; Affiliated Faculty, Yale Institute for Global Health

      Gary Désir M.D. is the Beeson Professor of Medicine at the Yale University School of Medicine (YSM) and serves as chair of the Department of Internal Medicine at YSM, and chair of the board of Yale Medicine.  He is a physician-scientist whose work has been funded by the National Science Foundation, National Institute of Health, Department of Veterans Affairs, American Heart Association, and the Robert Wood Johnson foundation. His major contributions to science include the discovery a specific voltage-gated potassium channel that regulates body weight and insulin sensitivity, and the identification of a new growth factor, which he named renalase. He elucidated the pathway through which renalase affects cellular signaling and discovered that the protein can function abnormally and facilitate the development of certain cancers. Hi laboratory is currently focused on developing drugs that can treat cancer by blocking the action of renalase in cancer cells. Dr. Désir is a named inventor on several patents related to the discovery and therapeutic use of renalase, and the development of drugs that modulate renalase signaling in cancer. He is the scientific founder of 2 biotechnology companies focused on developing renalase-based therapies.Dr. Désir, the first person of African descent to be appointed as chair of a department at YSM, has a strong interest in issues of diversity and social justice. He is the co-founder of the minority organization for retention and expansion (MORE), a faculty group at YSM focused on increasing faculty diversity through mentoring programs and developing resilient social networks. In collaboration with Gordon Geballe, Associate Dean for Alumni and External Affairs at school of Forestry and Environmental Studies, he has worked with L’Hospital Albert Schweitzer in the Artibonite valley in Haiti on integrated projects designed to improve the standard of living in the valley.  He was born in Port-Au-Prince, Haiti. After high school, he immigrated to the US to attend New York University, from which he graduated magna cum laude, with a bachelor’s degree in biology. He was elected to the Phi Beta Kappa Society, and also received New York University’s Founders Day award. Following graduation from Yale University School of Medicine (Cum Laude, Alpha Omega Alpha honor society), he trained in internal medicine and nephrology at Yale New Haven Hospital.  Dr. Désir is married to Dr. Deborah Dyett Désir who practices rheumatology at Yale. They have four children, Carl, Matthew, Christopher and Alexandra, a granddaughter Elodie and a grandson Amari.
    • Professor of Radiology and Biomedical Imaging; Chair, Radiology and Biomedical Imaging; Radiologist-in-Chief, Yale New Haven Health

      Rob Goodman, MB BChir, MBA is the Chair of the Department of Radiology & Biomedical Imaging at Yale School of Medicine, Chief of Radiology at Yale New Haven Hospital and Radiologist-in-Chief at Yale New Haven Health System.Dr. Goodman joined Yale in 2004 from the John Radcliffe Hospital in Oxford, UK, where he was lead clinician for its radiology department. He obtained his medical degree from Cambridge University in 1988 and an MBA in Healthcare from Yale in 2017. Upon completing his residency at the Central Oxford Hospitals in the UK, he did a fellowship in pediatric radiology at The Hospital for Sick Children in Toronto. After his relocation from Europe to the United States, he was struck by the marked differences in radiation awareness between the two countries, which is particularly relevant in pediatric radiology due to children’s susceptibility to the effects of radiation. He subsequently played a major role in the movement to reduce radiation exposure from CT scans in children, as well as adults. As a way to reduce radiation exposure, his clinical interests also included improved utilization of ultrasound in pediatric imaging. He has published and lectured on these topics nationally and is the Pediatric Community of Practice President for the American Institute for Ultrasound in Medicine, and sits on its Board of Governors. He has been involved in developing national consensus guidelines for such topics as neonatal echoencephalography, pediatric spinal ultrasound, hip ultrasound, and imaging in pregnant patients. During his tenure at Yale, Dr. Goodman has overseen the expansion of pediatric radiology services, spearheaded the installation of a dedicated pediatric MRI scanner at Yale New Haven Children’s Hospital, implemented a critical test result reporting system, and identified mechanisms to improve the radiology peer review process. He recently helped execute an imaging industry relationship with Siemens Healthcare for Yale New Haven Health System. As Chair, Dr. Goodman is building upon the department’s clinical strengths and world-class research taking place in such areas as novel MR pulse sequences, functional MRI, MR spectroscopy, novel PET tracers, and advanced image processing. By including industry partners, he is eager to expand its translational research program to help convert basic science discoveries into clinical applications that improve patient care.
    • Vice Provost for Health Affairs and Academic Integrity; University Title IX Coordinator; Clinical Professor of Obstetrics, Gynecology and Reproductive Services

      Dr. Spangler joined the Office of the Provost in 1995 and serves as provostial liaison for the Schools of Medicine, Nursing, and Public Health, Yale University Health Services, the Office of Environmental Health and Safety, and other health and biomedical units. She also oversees the Provost's Office of Academic Integrity, established in 2011, working with colleagues throughout the University to fortify and consolidate programs and procedures relating to academic integrity. Additionally, she is charged with leadership of University-wide Title IX compliance and related initiatives.Before assuming her present position, Dr. Spangler served as Director of Yale University Health Services, a health care delivery system serving faculty, employees, students, and their dependents. Dr. Spangler did her residency training at Yale-New Haven Hospital and holds an appointment as Clinical Professor in the Yale School of Medicine Department of Obstetrics, Gynecology, and Reproductive Sciences. From 2009 to 2011, she also held the position of Associate Vice President for West Campus Planning.
    • Professor of Medicine (Pulmonary); Vice Chair for Clinical Affairs, Internal Medicine; Director, Lung Cancer Screening Program

      Lynn Tanoue, MD, MBA is Professor in the Section of Pulmonary, Critical Care and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine. Dr. Tanoue received her undergraduate degree from Harvard and medical degree from Yale. She completed internal medicine residency, chief residency, and fellowship in pulmonary/critical care medicine at Yale New Haven Hospital. Her clinical interests focus on thoracic oncology and lung cancer screening. She is a founding member of the multidisciplinary Yale Cancer Center Thoracic Oncology Program and Director of the Yale Lung Screening and Nodule Program. She established the Yale New Haven Hospital Tuberculosis Outreach Program, which over the past twenty years has performed tuberculosis screening in thousands of English-as-a-Second-Language students enrolled at the New Haven Center for Adult Education. She has had numerous leadership roles at Yale New Haven Hospital, including as past president of the medical staff. Dr. Tanoue serves on numerous national committees; she is current chair of the American Thoracic Society Thoracic Oncology Assembly and a member of the ATS board of directors, serves on the American College of Chest Physicians lung cancer guidelines writing committee, is a member of the National Comprehensive Cancer Network lung cancer screening guidelines committee, and is current chair of the Pulmonary Medicine Board of the American Board of Internal Medicine.Learn more about Dr. Tanoue>>Dr. Tanoue is an active clinician, mentor, and educator at Yale, where she has received a number of awards including the Leffell Prize for Clinical Excellence, the Department of Internal Medicine Faculty Achievement Award for Clinical Care, the Dean’s Mentors Award, and the Leah Lowenstein Award.  Her contributions to Yale School of Medicine include the founding of the Yale Medical Symphony Orchestra, of which she is a member and President of its Board of Directors.